Label: ACEPROMAZINE MALEATE tablet

  • NDC Code(s): 86117-049-07, 86117-049-12, 86117-050-07, 86117-050-12
  • Packager: ZYVET ANIMAL HEALTH INC.
  • Category: PRESCRIPTION ANIMAL DRUG LABEL
  • DEA Schedule: None
  • Marketing Status: Abbreviated New Animal Drug Application

Drug Label Information

Updated November 10, 2023

If you are a consumer or patient please visit this version.

  • SPL UNCLASSIFIED SECTION

    For use in dogs only.

  • SPL UNCLASSIFIED SECTION

    Caution: Federal law restricts this drug to use by or on the order of a licensed veterinarian.

  • DESCRIPTION

    Description: Acepromazine maleate, a potent neuroleptic agent with a low order of toxicity, is of particular value in the tranquilization of dogs. Its rapid action and lack of hypnotic effect are added advantages.

  • SPL UNCLASSIFIED SECTION

    Chemistry: 2-acetyl-10-(3-dimethylaminopropyl) phenothiazine hydrogen maleate.

    Acepromazine Maleate

    image description

  • DESCRIPTION

    Mode of Action: Acepromazine maleate has a depressant effect on the central nervous system and therefore causes sedation, muscular relaxation and a reduction in spontaneous activity. It acts rapidly, exerting a prompt and pronounced calming effect. It is an effective preanesthetic agent and lowers the dosage requirement of general anesthetics.

  • SPL UNCLASSIFIED SECTION

  • SPL UNCLASSIFIED SECTION

  • VETERINARY INDICATIONS

    Indications: As an aid in tranquilization and as a preanesthetic agent in dogs.

    Acepromazine Maleate Tablets can be used as an aid in controlling intractable animals during examination, treatment, grooming, x-ray and minor surgical procedures.

  • DOSAGE & ADMINISTRATION

    Dosage and Administration: Dogs: 0.25-1.0 mg/lb of body weight. Dosage may be repeated as required.

  • ANIMAL PHARMACOLOGY & OR TOXICOLOGY

    Animal Safety: Acute and chronic toxicity studies have shown a very low order of toxicity for acepromazine maleate.

    A safety study using elevated dosages of acepromazine maleate demonstrated no adverse reactions even when administered at three times the upper limit of the recommended daily dosage (3.0 mg/lb body weight). The clinical observation for this high dosage was mild depression which disappeared in most dogs 24 hours after termination of dosing.

    The only occurrence of adverse reaction during numerous clinical trials was a very mild respiratory distress (reverse sneeze) which was transient in nature and had no effect on the desired action of the drug.

  • CONTRAINDICATIONS

    Contraindications: Phenothiazines may potentiate the toxicity of organophosphates. Therefore, do not use acepromazine maleate to control tremors associated with organic phosphate poisoning.

    Do not use in conjunction with organophosphorus vermifuges or ectoparasiticides, including flea collars.

    Do not use with procaine hydrochloride.

  • WARNINGS

    Warning: Do not use in animals intended for human consumption.

    Keep Acepromazine Maleate Tablets in a secure location out of reach of dogs, cats, and other animals to prevent accidental ingestion or overdose.

  • PRECAUTIONS

    Precautions: Tranquilizers are potent central nervous system depressants, and they can cause marked sedation with suppression of the sympathetic nervous system. Tranquilizers can produce prolonged depression or motor restlessness when given in excessive amounts or when given to sensitive animals.

    Tranquilizers are additive in action to the actions of other depressants and will potentiate general anesthesia. Tranquilizers should be administered in smaller doses and with greater care during general anesthesia and also to animals exhibiting symptoms of stress, debilitation, cardiac disease, sympathetic blockade, hypovolemia or shock. Acepromazine, like other phenothiazine derivatives, is detoxified in the liver; therefore, it should be used with caution on animals with a previous history of liver dysfunction or leukopenia.

    Epinephrine is contraindicated for treatment of acute hypotension produced by phenothiazine-derivative tranquilizers since further depression of blood pressure can occur.

    Phenothiazines should be used with caution when followed by epidural anesthetic procedures because they may potentiate the arterial hypotensive effects of local anesthetics.

  • ADVERSE REACTIONS

    Adverse Reactions: A few rare but serious occurrences of idiosyncratic reactions to acepromazine may occur in dogs following oral or parenteral administration. These potentially serious adverse reactions include behavioral disorders in dogs such as aggression, biting/chewing, and nervousness.

    To report suspected adverse drug events, for technical assistance or to obtain a copy of the Safety Data Sheet (SDS), contact ZyVet Animal Health Inc. at 1-877-779-9838.

    For additional information about adverse drug experience reporting for animal drugs, contact FDA at 1-888-FDA-VETS or http://www.fda.gov/reportanimalae

  • STORAGE AND HANDLING

    Storage: Store at 20° - 25°C (68° - 77°F). Excursions permitted to 40°C (104°F).

  • HOW SUPPLIED

    How Supplied: Acepromazine Maleate Tablets are available in 10 and 25 mg quarter-scored tablets and are supplied in bottles containing 100 and 500 tablets.

    NDC 86117-049-07 – 10 mg – 100 tablets

    NDC 86117-049-12 – 10 mg – 500 tablets

    NDC 86117-050-07 – 25 mg – 100 tablets

    NDC 86117-050-12 – 25 mg – 500 tablets

    Approved by FDA under ANADA # 200-757

  • SPL UNCLASSIFIED SECTION

    Manufactured by:
    Zydus Animal Health and Investments Limited, Ahmedabad, India.


    Distributed by:
    ZyVet Animal Health Inc.
    Pennington, NJ 08534

  • Principal Display Panel - Bottle Label, 10 mg – 100 Tablets

    NDC 86117-049-07

    Acepromazine

    Maleate Tablets

    10 mg

    Caution: Federal law restricts this drug to use by or on the order of a licensed veterinarian.

    Approved by FDA under ANADA # 200-757

    Net Contents:

    100 Tablets

    10 mg 100 Count

  • Principal Display Panel - Bottle Label, 10 mg – 500 Tablets

    NDC 86117-049-12

    Acepromazine

    Maleate Tablets

    10 mg

    Caution: Federal law restricts this drug to use by or on the order of a licensed veterinarian.

    Approved by FDA under ANADA # 200-757

    Net Contents:

    500 Tablets

    10 mg 500 Count

  • Principal Display Panel - Bottle Label, 25 mg – 100 Tablets

    NDC 86117-050-07

    Acepromazine

    Maleate Tablets

    25 mg

    Caution: Federal law restricts this drug to use by or on the order of a licensed veterinarian.

    Net Contents:

    100 Tablets

    25 mg 100 Count

  • Principal Display Panel - Bottle Label, 25 mg – 500 Tablets

    NDC 86117-050-12

    Acepromazine

    Maleate Tablets

    25 mg

    Caution: Federal law restricts this drug to use by or on the order of a licensed veterinarian.

    Approved by FDA under ANADA # 200-757

    Net Contents:

    500 Tablets

    25 mg 500 Count

  • INGREDIENTS AND APPEARANCE
    ACEPROMAZINE MALEATE 
    acepromazine maleate tablet
    Product Information
    Product TypePRESCRIPTION ANIMAL DRUGItem Code (Source)NDC:86117-049
    Route of AdministrationORAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    ACEPROMAZINE MALEATE (UNII: 37862HP2OM) (ACEPROMAZINE - UNII:54EJ303F0R) ACEPROMAZINE MALEATE10 mg
    Product Characteristics
    ColorPINK (Light pink to peach) Score4 pieces
    ShapeROUNDSize8mm
    FlavorImprint Code 35;U
    Contains    
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:86117-049-07100 in 1 BOTTLE
    2NDC:86117-049-12500 in 1 BOTTLE
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    ANADAANADA20075712/01/2023
    ACEPROMAZINE MALEATE 
    acepromazine maleate tablet
    Product Information
    Product TypePRESCRIPTION ANIMAL DRUGItem Code (Source)NDC:86117-050
    Route of AdministrationORAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    ACEPROMAZINE MALEATE (UNII: 37862HP2OM) (ACEPROMAZINE - UNII:54EJ303F0R) ACEPROMAZINE MALEATE25 mg
    Product Characteristics
    ColoryellowScore4 pieces
    ShapeROUNDSize8mm
    FlavorImprint Code 37;U
    Contains    
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:86117-050-07100 in 1 BOTTLE
    2NDC:86117-050-12500 in 1 BOTTLE
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    ANADAANADA20075712/01/2023
    Labeler - ZYVET ANIMAL HEALTH INC. (117047560)
    Registrant - ZYVET ANIMAL HEALTH INC. (117047560)